Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark Cream

New Treatment Approach Gives Patients With Incurable Lung Cancer More Time Without Disease Progression Compared To Placebo
Results from a Phase III study presented at the American Society for Clinical Oncology (ASCO) Annual Meeting in Orlando, Florida today show that patients with advanced non-small cell lung cancer (NSCLC) who received erlotinib (Tarceva®) as first-line maintenance treatment benefited from a significant (29%) improvement in the time they lived without the disease advancing, compared with those who received placebo1. Patients in the global multicentre SATURN trial, which included patients from the UK, received maintenance treatment with erlotinib if their cancer had not progressed on initial chemotherapy. The data showed a significant improvement in the length of time patients lived without their disease getting worse, and without the need for further chemotherapy. 1 The improvement was seen in both of the main types of NSCLC (squamous cell as well as non-squamous cell) and these results form the basis of a submission for regulatory approval of erlotinib to be used in the first-line maintenance setting. 1 Erlotinib is not currently licensed for first line maintenance treatment in NSCLC lung cancer in the UK.
generic viagra online
Why Winning Athletes Are Getting Bigger
While watching swimmers line up during the 2008 Olympic Games in Beijing, former Olympic swimmer and NBC Sports commentator Rowdy Gaines quipped that swimmers keep getting bigger, with the shortest one in the current race towering over the average spectator. Drugshop to buy zoloft online and other pills.
News of the day
Nearly Half Of Rheumatoid Arthritis Sufferers Feel Early Treatment Would Have Given Them More Independence
A UK survey of 575 rheumatoid arthritis sufferers highlights the importance of maintaining independence and the significant impact that early diagnosis and treatment can have. Over 94% of those surveyed claimed that their independence was compromised in some way, with over 60% saying it was compromised significantly. With earlier treatment of their disease, nearly half of the respondents felt that they would have been more independent today, making it vital that people are aware of the significance of early intervention.
Endocrinology

TREAT TB Web Portal Launched

The Union-managed initiative TREAT TB (Technology, Research, Education and Technical Assistance for TB) is now on the web offering direct access to the work of this five-year, USAID-funded project. The new Union-managed initiative TREAT TB (Technology, Research, Education and Technical Assistance for TB) now has a web portal. You can go directly to http://www.treattb.org or access the portal via the Tuberculosis Department web site to learn more about this 5-year, USAID-funded project. The goals of TREAT TB are to contribute to new knowledge through field evaluations of diagnostic tools, clinical trials of priority research questions, and targeted operational research benefitting global regional and country TB control efforts. Using the web portal, you will be able to: - Stay up-to-date on important news about TREAT TB - Learn more about TREAT TB partners - Get the latest TB-related news from around the world - Download documents about TREAT TB and its activities TREAT TB is managed by The Union North America Office in New York. For more information, please visit http://www.treattb.org, call +1 212 500 5720, or email Bruno Bui, Project Administrator, at bbui@theunion.org . TREAT TB


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009